BIO-RAD LABORATORIES, INC. (BIO-B) › Capital ExpendituresBIO-RAD LABORATORIES, INC. (BIO-B) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2009: $68.04M2010: $88.45M2011: $102.89M2012: $142.87M2013: $106.66M2014: $121.00M2015: $112.00M2016: $141.44M2017: $111.33M2018: $129.82M2019: $98.53M2020: $108.56M2021: $133.75M2022: $112.80M2023: $156.70M2024: $165.60M2025: $157.60M$157.60M2009Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$157.60M-4.8%2024$165.60M+5.7%2023$156.70M+38.9%2022$112.80M-15.7%2021$133.75M+23.2%2020$108.56M+10.2%2019$98.53M-24.1%2018$129.82M+16.6%2017$111.33M-21.3%2016$141.44M+26.3%2015$112.00M-7.4%2014$121.00M+13.4%2013$106.66M-25.3%2012$142.87M+38.9%2011$102.89M+16.3%2010$88.45M+30.0%2009$68.04M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share